US Patent

US9687611 — Injection device with torsion spring and rotatable display

Formulation · Assigned to Novo Nordisk AS · Expires 2027-02-27 · 1y remaining

Vulnerability score 51/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an injection device with a torsion spring and rotatable display for setting and displaying a dose to be ejected.

USPTO Abstract

The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof.

Drugs covered by this patent

Patent Metadata

Patent number
US9687611
Jurisdiction
US
Classification
Formulation
Expires
2027-02-27
Drug substance claim
No
Drug product claim
Yes
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.